Bristol-Myers Squibb Company
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.
POSTED
02-22-23
Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms
Kareem Abdul-Jabbar is teaming up with Bristol Myers Squibb and Pfizer to raise awareness of atrial fibrillation (AFib) and its symptoms as part of the No Time to Wait campaign.
POSTED
02-07-23
Reflecting on Research in Genitourinary Cancers
Hi, my name is Dana Walker. I’m the development program lead for genitourinary cancers here at Bristol Myers Squibb. I’m proud to lead a team of people continuing to develop treatments that help improve and extend the lives of patients dealing with genitourinary cancers.
POSTED
01-30-23
The Power of Dual Immunotherapy
A decade ago, the evolution of immuno-oncology transformed the landscape of therapy for patients with many cancers. Although individual immunotherapies have helped to improve outcomes for patients.
POSTED
01-20-23
The Robert A. Winn Diversity in Clinical Trials Award Program Established by the Bristol Myers Squibb Foundation To Expand With Amgen’s Commitment of $8 Million
The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Award Program) established by the Bristol Myers Squibb Foundation (BMSF) announced that Amgen, a global biotechnology company, has committed to contribute $8 million over the next four years.
POSTED
01-06-23
Biking the Globe for C2C4C
A handful of inspirational words from author Scott Stoll served as the rallying cry for more than 350 Bristol Myers Squibb employees representing 23 nations who successfully trained and participated in four regional bicycle rides collectively known as C2C4C.
POSTED
12-21-22
Moments of Serendipity As Our Teams 'Light the Night'
The experience was “miraculous” for Asalia, and this story is one of countless from the annual walks that support the Leukemia and Lymphoma Society (LLS), with which Bristol Myers Squibb has had a long-standing partnership.
POSTED
12-07-22
Cancer Care Milestone Reached in Lesotho
For too many years, cancer patients in Lesotho felt life-changing cancer treatment was out of reach. No oncology clinics existed in their landlocked country ringed by steep mountains and surrounded by South Africa.
POSTED
11-09-22
Lung Cancer Is Personal: Interview With Lee James
Each November marks Lung Cancer Awareness Month in the United States. Lung cancer is the leading cause of cancer deaths in the country, taking more lives than breast, colon and prostate cancers combined.
POSTED
11-02-22
A Beacon of Hope
Bristol Myers Squibb has a long-standing partnership with The Leukemia & Lymphoma Society (LLS) and has been the top biopharma fundraising team for Light The Night® for more than a decade.
POSTED
10-26-22
The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of Physicians to be Trained in the $114 Million Program
The Bristol Myers Squibb Foundation (BMSF) announced that an additional 64 physicians have been selected to receive the Robert A. Winn Diversity in Clinical Trials Career Development Award (Winn CDA).
